Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program

BACKGROUND: Medications such as buprenorphine are considered the gold standard for the treatment of opioid use disorders. This study aimed to determine whether less restrictive buprenorphine prescribing practices during the COVID-19 pandemic impacted retention in and adherence to buprenorphine among...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Kathleen M., Scheim, Ayden, Wang, Jonathan, Cocchiaro, Benjamin, Singley, Katie, Roth, Alexis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040407/
https://www.ncbi.nlm.nih.gov/pubmed/35497489
http://dx.doi.org/10.1016/j.dadr.2022.100055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040407/
https://www.ncbi.nlm.nih.gov/pubmed/35497489
http://dx.doi.org/10.1016/j.dadr.2022.100055

Ejemplares similares